P. Gabow

发表

Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease

Ann M. Johnson, P. Gabow, W. D. Kaehny, 1992, Pediatric Nephrology.

The Effect of Automated Alerts on Provider Ordering Behavior in an Outpatient Setting

P. Gabow, A. W. Steele, S. Eisert, 2005, PLoS medicine.

PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein

Patricia A. Gabow, William J. Kimberling, Martijn H. Breuning, 1996, Science.

Renal asymmetry in children with autosomal dominant polycystic kidney disease.

P. Gabow, G. Fick-Brosnahan, A. Johnson, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Characteristics of very early onset autosomal dominant polycystic kidney disease

Ann M. Johnson, P. Gabow, W. Kimberling, 1993, Pediatric Nephrology.

Renal structure and hypertension in autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, W. D. Kaehny, 1990, Kidney international.

Progression of autosomal-dominant polycystic kidney disease in children.

Ann M. Johnson, P. Gabow, Z. Tran, 2001, Kidney international.

Diuretics versus Angiotensin-Converting Enzyme Inhibitors in Autosomal Dominant Polycystic Kidney Disease

Ann M. Johnson, P. Gabow, A. Chapman, 2001, American Journal of Nephrology.

Frequency of ovarian cysts in patients with autosomal dominant polycystic kidney disease.

R. Townsend, P. Gabow, A. Johnson, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease.

P. Gabow, I. Duley, A. Johnson, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, A. Chapman, 1997, Journal of the American Society of Nephrology : JASN.

Autosomal dominant polycystic kidney disease.

P. Gabow, P A Gabow, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen.

P. Gabow, A. Chapman, A. Johnson, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease.

P. Gabow, A. Chapman, R. Schrier, 1991, Annals of internal medicine.

Echocardiographic findings in autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, R. Schrier, 1988, The New England journal of medicine.

Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant.

D. Pretorius, P. Gabow, M. Manco-Johnson, 1987, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Percutaneous cyst puncture in the treatment of cyst infection in autosomal dominant polycystic kidney disease.

P. Gabow, A. Chapman, D. Thickman, 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Intracranial aneurysms in autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, W. D. Kaehny, 1992, The New England journal of medicine.

Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, A. Chapman, 1994, Journal of the American Society of Nephrology : JASN.

The spectrum of autosomal dominant polycystic kidney disease in children.

Ann M. Johnson, P. Gabow, I. Duley, 1994, Journal of the American Society of Nephrology : JASN.

Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease.

P. Gabow, W. Kimberling, A. Johnson, 1995, Journal of the American Society of Nephrology : JASN.

Utility of ultrasonography in the diagnosis of autosomal dominant polycystic kidney disease in children.

P. Gabow, W. Kimberling, A. Johnson, 1997, Journal of the American Society of Nephrology : JASN.

Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease.

Ann M. Johnson, R. Townsend, P. Gabow, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, W. D. Kaehny, 2003, Kidney international.

Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up.

Ann M. Johnson, P. Gabow, W. D. Kaehny, 2004, Journal of the American Society of Nephrology : JASN.

Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, A. Johnson, 1998, Journal of the American Society of Nephrology : JASN.

Ten strategies to lower costs, improve quality, and engage patients: the view from leading health system CEOs.

B. James, J. Perlin, Glenn D. Steele, 2013, Health affairs.

The role of alcohol in new-onset atrial fibrillation.

S. Lowenstein, P. Gabow, P. B. Oliva, 1983, Archives of internal medicine.

Early Polycystic Kidney Disease

P. Gabow, J. Holmes, 1985 .

Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease.

P. Gabow, D. Lezotte, R. Schrier, 1990, American journal of medical genetics.

Syndromes of toluene sniffing in adults.

P. Gabow, W. D. Kaehny, A. Moss, 1981, Annals of internal medicine.

Disorders associated with an altered anion gap.

P. Gabow, 1985, Kidney international.

The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, A. Chapman, 1990, The New England journal of medicine.

A broad and structured approach to improving patient safety and quality: lessons from Denver Health.

P. Gabow, P. Mehler, 2011, Health affairs.

Clinical effect of morning report.

R. Anderson, P. Gabow, W. D. Kaehny, 1993, Academic medicine : journal of the Association of American Medical Colleges.

A new method for studying human polycystic kidney disease epithelia in culture.

P. Wilson, P. Gabow, R. Schrier, 1986, Kidney international.

Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease.

S. Thibodeau, P. Gabow, V. Torres, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Nonoliguric acute renal failure.

R. Anderson, P. Gabow, R. Schrier, 1977, The New England journal of medicine.

Separate or United: The Safety Net in the Era of Health Care Integration

P. Gabow, Mark W. Smith, 2017, Journal of health care for the poor and underserved.

Changes in Insurance Status and Access to Care in an Integrated Safety Net Healthcare System

Patricia A. Gabow, Susan L. Moore, P. Gabow, 2009, Journal of Community Health.

Effect of Child Health Insurance Plan enrollment on the utilization of health care services by children using a public safety net system.

P. Gabow, S. Eisert, 2002, Pediatrics.

Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease.

K. Klinger, P. Gabow, W. Kimberling, 1999, American journal of human genetics.

Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin.

Ann M. Johnson, P. Gabow, W. Kimberling, 1994, Journal of the American Society of Nephrology : JASN.

Hypertension in autosomal dominant polycystic kidney disease

P. Gabow, A. Chapman, F. Rahbari-Oskoui, 2013 .

Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease.

Ann M. Johnson, P. Gabow, A. Johnson, 1997, Journal of the American Society of Nephrology : JASN.

Genetic Counseling in ESRD Patients with Polycystic Kidney Disease

P. Gabow, 1991 .

Epidemiology of Autosomal Dominant Polycystic Kidney Disease: Implications for Genetic Counseling

P. Gabow, 1990 .

Hypertension in autosomal dominant polycystic kidney disease.

P. Gabow, R. Schrier, A. Johnson, 1988, Kidney international.

Introduction: Autosomal Dominant Polycystic Kidney Disease

P. Gabow, 1993 .

Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates.

P. Gabow, W. D. Kaehny, W. Kimberling, 1990, The American journal of medicine.

Severe acid-base abnormalities associated with cocaine abuse.

P. Gabow, J. Marx, T. R. Drake, 1990, The Journal of emergency medicine.

Natural history of autosomal dominant polycystic kidney disease.

P. Gabow, G. Fick, 1994, Annual review of medicine.

The Spectrum of Rhabdomyolysis

P. Gabow, W. D. Kaehny, S. Kelleher, 1982, Medicine.

The role of alcohol in new-onset atrial fibrillation.

S. Lowenstein, P. Gabow, P. B. Oliva, 1983, Archives of internal medicine.

Prediction of Likelihood of Polycystic Kidney Disease in the Fetus When a Parent has Autosomal Dominant Polycystic Kidney Disease

P. Gabow, L. Wilkins-Haug, 1991 .

Acid-base disturbances in the salicylate-intoxicated adult.

D. E. Potts, R. Anderson, P. Gabow, 1978, Archives of internal medicine.

Articles Improving Identification of and Intervention for Alcoholism

P. Gabow, D. Lezotte, P. Mehler, 2005 .

Diagnostic importance of an increased serum anion gap.

P. Gabow, W. D. Kaehny, R. Schrier, 1980, The New England journal of medicine.

Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia

P. Wilson, P. Gabow, D. Hreniuk, 1992, Journal of cellular physiology.

Nonoliguric acute renal failure.

R. J. Anderson, R. Anderson, P. Gabow, 1977, The New England journal of medicine.

Urinary diagnostic indices in acute renal failure: a prospective study.

R. Anderson, P. Gabow, R. Schrier, 1978, Annals of internal medicine.

Spironolactone-induced hyperchloremic acidosis in cirrhosis.

P. Gabow, R. Schrier, S. Moore, 1979, Annals of internal medicine.

Unrecognized adult salicylate intoxication.

D. E. Potts, R. Anderson, P. Gabow, 1977, Annals of internal medicine.

Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, W. D. Kaehny, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Fanconi's syndrome and distal renal tubular acidosis after glue sniffing.

P. Gabow, W. D. Kaehny, A. Moss, 1980, Annals of internal medicine.

Denver Health: A Model for the Integration of a Public Hospital and Community Health Centers

P. Gabow, S. Eisert, Richard A. Wright, 2003, Annals of Internal Medicine.

Court-Ordered Alcohol Treatment for Patients with Medical Problems

C. Steiner, P. Gabow, D. Lezotte, 1995 .

CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.

P. Gabow, O. Devuyst, G. Brosnahan, 2000, Journal of the American Society of Nephrology : JASN.

Organic acids in ethylene glycol intoxication.

P. Gabow, J. B. Sullivan, R. Lepoff, 1986, Annals of internal medicine.

Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, W. D. Kaehny, 1992 .

Genetic studies in a black family with autosomal dominant polycystic kidney disease and sickle-cell trait.

P. Gabow, W. Kimberling, A. Johnson, 1996, Nephron.

Ethylene glycol intoxication.

P. Gabow, 1988, American Journal of Kidney Diseases.

Linkage heterogeneity of autosomal dominant polycystic kidney disease.

P. Gabow, W. Kimberling, P. Fain, 1988, The New England journal of medicine.

Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23.

P. Gabow, W. Kimberling, S. Somlo, 1993, Genomics.

Segregation analysis of autosomal dominant polycystic kidney disease

Y. Shugart, P. Gabow, W. Kimberling, 1993, Genetic epidemiology.

The fall of the serum anion gap.

P. Gabow, S. D. Winter, J. Pearson, 1990, Archives of internal medicine.

Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. S. St George-Hyslop, E. Coto, 2003, Journal of the American Society of Nephrology : JASN.

Renal manifestations: complication management and long-term outcome of autosomal dominant polycystic kidney disease.

P. Gabow, W. Bennett, 1991, Seminars in nephrology.

Hereditary and acquired cystic disease of the kidney.

P. Gabow, G. Fick, G. M. Fick, 1994, Kidney international.

Unrecognized Adult Salicylate Intoxication

Robert J. Anderson, D. E. Potts, P. Gabow, 1976 .

Arteriovenous fistula from drug abuse. Implications for hemodialysis.

P. Gabow, A. de Torrenté, S. Holt, 1976, JAMA.

Toluene Abuse During Pregnancy: Obstetric Complications and Perinatal Outcomes

P. Gabow, L. Wilkins-Haug, PATRICIA A. GABOW, 1991, Obstetrics and gynecology.

Psychogenic adipsia in a patient with psychotic depression.

P. Gabow, M. G. Phillips, 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Autosomal dominant polycystic kidney disease--more than a renal disease.

P. Gabow, P. Gabow, 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Autosomal dominant polycystic kidney disease.

P. Gabow, 2010, The New England journal of medicine.

Adrenal insufficiency after unilateral radical nephrectomy.

P. Gabow, J. Goldberg, M. Lucas, 1976, Urology.

RENAL CELL CARCINOMA: UNUSUAL SYSTEMIC MANIFESTATIONS

P. Gabow, W. D. Kaehny, R. Schrier, 1976, Medicine.

Polycystic kidney disease: clues to pathogenesis.

P. Gabow, 1991, Kidney international.

Polycystic kidney disease: prospective analysis of nonazotemic patients and family members.

P. Gabow, J. Holmes, D. Iklé, 1984, Annals of internal medicine.

12 Autosomal Dominant Polycystic Kidney Disease

P. Gabow, 1990 .

The clinical utility of renal concentrating capacity in polycystic kidney disease.

Ann M. Johnson, P. Gabow, W. D. Kaehny, 1989, Kidney international.

Pathophysiology of adult polycystic kidney disease.

P. Gabow, R. Schrier, 1989, Advances in nephrology from the Necker Hospital.

Polycystic liver disease: Quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts

J. Reichen, A. Scherzinger, P. Gabow, 1988, Hepatology.

Exclusion of autosomal dominant polycystic kidney disease type II (ADPKD2) from 160 cM of chromosome 1.

Y. Shugart, P. Gabow, W. Kimberling, 1990, Journal of medical genetics.

Progress in blood pressure control in autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, I. Duley, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

For many patients who use large amounts of health care services, the need is intense yet temporary.

Patricia Gabow, P. Gabow, H. Batal, 2015, Health affairs.

Concepts and controversies in salicylate toxicity.

L. Yip, P. Gabow, R. Dart, 1994, Emergency medicine clinics of North America.

Frequently nebulized β-agonists for asthma : effects on serum electrolytes

John A. Marx, Patricia A. Gabow, Steven R. Lowenstein, 1992 .

Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, I. Duley, 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Autosomal dominant polycystic kidney disease in childhood: a longitudinal study.

P. Gabow, R. Schrier, M. Manco-Johnson, 1987, Kidney international.

Causes of death in autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, A. Johnson, 1995, Journal of the American Society of Nephrology : JASN.

Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease

Ann M. Johnson, P. Gabow, W. D. Kaehny, 1990, Hepatology.

Tubulointerstitial and glomerular nephritis associated with rifampin. Report of a case.

P. Gabow, T. Neff, J. Lacher, 1976, JAMA.

Genetic linkage studies of autosomal dominant polycystic kidney disease: search for the second gene in a large Sicilian family

P. Gabow, W. Kimberling, Shrawan Kumar, 1991, Human Genetics.

ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease Presence of De Novo Mutations in Autosomal Dominant Polycystic Kidney Disease Patients Without Family History

Ann M. Johnson, P. Gabow, W. Kimberling, 2008 .

Is there evidence for anticipation in autosomal-dominant polycystic kidney disease?

Ann M. Johnson, P. Gabow, A. Johnson, 1994, Kidney international.

Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease.

Ann M. Johnson, P. Gabow, A. Chapman, 1994, Journal of the American Society of Nephrology : JASN.

Can America’s Urban Safety Net Systems be a Solution to Unequal Treatment?

P. Gabow, S. Eisert, P. Mehler, 2008, Journal of Urban Health.

Outcomes and Lessons Learned

P. Gabow, P. Goodman, 2014 .

Evaluating patient compliance with nurse advice line recommendations and the impact on healthcare costs.

Patricia Gabow, Richard C Dart, P. Gabow, 2004, The American journal of managed care.

Von Hippel-Lindau disease masquerading as autosomal dominant polycystic kidney disease.

R. Townsend, P. Gabow, P. Rothberg, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A peer approach to high risk youth.

P. Gabow, S. Hritz, 1997, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Prevalence of psychiatric disorders and costs of care among adult enrollees in a Medicaid HMO.

Marshall R. Thomas, P. Gabow, K. Rost, 2005, Psychiatric services.

Observations of Residents’ Work Activities for 24 Consecutive Hours: Implications for Workflow Redesign

Andrew Knight, P. Gabow, S. Eisert, 2006, Academic medicine : journal of the Association of American Medical Colleges.

Insurance for autosomal dominant polycystic kidney disease patients prior to end-stage renal disease.

P. Gabow, A. Johnson, G. Fick, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

THE COMMONWEALTH FUND Commission on a High Performance Health System

Maureen Bisognano, Christine K. Cassel, Patricia Gabow, 2005 .

Influence of Not-for-Profit Hospital Ownership Type on Community Benefit and Charity Care

P. Gabow, Hosseinali Zare, 2022, Journal of Community Health.

Innovation and Best Practices in Health Care Scheduling

John Toussaint, Patricia A. Gabow, Glenn D. Steele, 2015 .

Using computerized clinical decision support for latent tuberculosis infection screening.

Nedra Garrett, Patricia Gabow, P. Gabow, 2005, American journal of preventive medicine.

Intra- and extracellular proteins in human normal and polycystic kidney epithelial cells.

P. Gabow, R. Schrier, V. Van Putten, 1990, Kidney international.

Frequently nebulized beta-agonists for asthma: effects on serum electrolytes.

S. Lowenstein, P. Gabow, J. Marx, 1992, Annals of Emergency Medicine.

AUTHORS Lisa Brandenburg President Seattle Children ’ s Hospital Patricia Gabow Former Chief Executive Officer Denver Health Glenn Steele President and Chief Executive Officer Geisinger Health System John Toussaint Chief Executive Officer ThedaCare Center for Healthcare Value

Glenn D. Steele, P. Gabow, J. Toussaint, 2015 .

Furosemide-induced reduction in ionized calcium in hypoparathyroid patients.

P. Gabow, R. Schrier, M. Popovtzer, 1977, Annals of internal medicine.

Comparison of Hospitalization Between Nursing Home and Community Residents

P. Gabow, D. Lezotte, D. Hutt, 1985, Journal of the American Geriatrics Society.